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How this fits in 
Smoking cessation improves health outcomes for adults with coronary heart disease and 
primary care practitioners are well placed to support people to stop smoking.  This study has 
shown that the quality of smoking cessation care provided in primary care was generally high 
for adults with CHD, but that more targeted support for particular groups (those from 
deprived areas and those with mental health problems) is required. 
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Abstract  
Background: Smoking cessation is a core part of the primary care management of CHD but 
little is known about how smoking cessation practices differ for patients with different co-
morbidities. 
 
Aim: To determine the association between different patterns of co-morbidity and smoking 
rates and smoking cessation interventions in primary care for patients with CHD. 
 
Design and Setting: Cross-sectional study of 81,456 adults with CHD in primary care in 
Scotland. 
 
Method: Details of eight ‘concordant’ physical co-morbidities (i.e. conditions where 
smoking cessation is critical), 23 ‘discordant’ physical co-morbidities and eight mental health 
co-morbidities were extracted from electronic health records. Outcome measures were 
smoking status, smoking cessation advice recorded, and smoking cessation medication 
(nicotine replacement therapy, NRT) prescribed. Multilevel binary logistic regression models 
were constructed to determine the association between these patterns of co-morbidity and 
smoking status and the two smoking cessation interventions.  
 
Results: The most deprived quintile had nearly three times higher odds of being current 
smokers than the least deprived (OR 2.76, 95% CI 2.49 to 3.05).  People with CHD and two 
or more mental health co-morbidities had more than twice the odds of being current smokers 
than those with no mental health conditions (OR 2.11, 95% CI 1.99 to 2.24).  Despite this, 
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those with two or more mental health co-morbidities (OR 0.77, 95% CI 0.61 to 0.98) were 
less likely to receive smoking cessation advice, but absolute differences were small.   
 
Conclusions: Patterns of co-morbidity are associated with variation in smoking status and the 
delivery of smoking cessation advice among people with CHD in primary care.  Those from 
the most deprived areas and those with mental health problems are considerably more likely 
to be current smokers and require additional smoking cessation support.  
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INTRODUCTION 
Coronary heart disease (CHD) is the leading cause of death worldwide.(1) It is now 
recognised that most people with CHD have additional co-morbidities, with important 
implications for how patients are treated and how services are organised.(2, 3)  The type of 
co-morbidity is important too, as different conditions may be more or less challenging to 
manage alongside CHD.  For example, ‘concordant’ physical conditions such as hypertension 
that share the same pathophysiological risk profile as CHD, are more likely to share the same 
treatment and self-management plan and are likely to present fewer problems in management 
than ‘discordant’ physical conditions that are not directly related in either their pathogenesis 
or management.(4)  Similarly, patients with CHD and mental health co-morbidities may not 
receive optimal care of physical conditions if they are mostly seen by mental health teams.(5) 
 
Tobacco smoking is one of the main risk factors for the development of CHD (6) and 
stopping smoking reduces the risk of mortality in individuals with established CHD.(7, 8) 
Smoking cessation practice in UK primary care involves three strands: (i) recording of 
smoking status; (ii) offering ‘brief interventions’(9) involving advice and encouragement to 
stop smoking; and (iii) offering nicotine replacement therapy (NRT) or other smoking 
cessation medication and/or referral to specialist smoking cessation services. 
 
Since 2004, the Quality and Outcomes Framework (QOF) incentivised UK GPs to provide 
smoking cessation interventions with smokers who have certain chronic conditions, including 
CHD, which are regarded as a priority for smoking cessation.  Yet there has been relatively 
little research into the quality of smoking cessation practice for patients with CHD in UK 
primary care.(10) This study uses individual level data to explore the relationship between 
three strands of smoking cessation practice (recorded smoking status, smoking cessation 
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advice and NRT prescribing) and three different patterns of co-morbidity in patients with 
CHD, taking account of age, sex, deprivation, and the effect of clustering by practice. 
 
The following three research questions were posed:   
1. Does current smoking status in people with CHD vary by patterns of co-morbidity?  
2. Does receipt of smoking cessation advice in current smokers with CHD vary by patterns 
of co-morbidity? 
3. Does receipt of smoking cessation medication in current smokers with CHD vary by 
patterns of co-morbidity? 
 
METHODS 
Study design and population 
An observational cross-sectional study design was applied using population data from GP 
electronic medical records for one third of the Scottish population, which has previously been 
used to examine the prevalence of multimorbidity in the Scottish population and has been 
fully described in a previous paper.(2)  The data used were extracted from a dataset held by 
the Primary Care Clinical Informatics Unit (PCCIU) at the University of Aberdeen. The 
dataset comprises complete copies of clinical data for all registered patients from 314 general 
practices caring for 1,754,133 registered patients, approximately one-third of the Scottish 
population.  Data was collected between April 2006 and March 2007.  The dataset has 
previously been shown to be representative of all Scottish patients in terms of age, sex and 
socio-economic status.(11)  
 
Study variables 
Smoking cessation practice 
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The three outcomes of interest in this study were: (i) recorded smoking status, (ii) recorded 
smoking cessation advice in the last 15 months, and (iii) recorded Nicotine Replacement 
Therapy (NRT) prescribing in the last 15 months.  Recorded smoking status was based on 30 
Read Codes (the standard coding system used in UK primary care) in the original dataset re-
coded into ‘Ex-Smoker/Never Smoked’ or ‘Current Smoker’. Previous research has found 
good validity of GP recording of smoking status, comparable to nationally representative 
population surveys.(12-15) 
 
Recorded smoking cessation advice in the last 15 months (the timeframe used for QOF) was 
based on 21 different read codes re-coded into ‘Advice recorded’ or ‘Advice not recorded’ 
(defined as the absence of a smoking cessation advice code).  This timeframe was also used 
for recorded NRT prescribing, which was defined as nicotine replacement therapy in British 
National Formulary section 4.10.2.  All types of NRT – patches, gum, etc – were grouped 
together.    Read Code lists are provided in Appendix 1.  
 
Co-morbidities 
Data on the presence of 40 conditions (i.e. CHD and 39 co-morbid conditions) was 
previously extracted by a team of researchers, including SM and BG, and has been described 
in detail elsewhere.(2)  The present study explored the effect of three different patterns of co-
morbidity on smoking cessation practice.  These were: concordant physical co-morbidities, 
defined as physical conditions (vascular and respiratory) for which smoking is a significant 
risk factor and for which smoking cessation is considered critical; discordant physical co-
morbidities (the remaining physical conditions where smoking cessation is less critical); and 
co-morbid mental health conditions.  For all three patterns, we used a simple unweighted 
count of 0, 1, or ≥ 2 conditions.  There were eight concordant physical conditions: five 
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broadly ‘vascular’ (hypertension, diabetes, chronic kidney disease (CKD), stroke/TIA, and 
peripheral vascular disease (PVD)) and three ‘respiratory’ (asthma, chronic obstructive 
pulmonary disease (COPD) and bronchiectasis).  These conditions were considered to be 
concordant in relation to smoking cessation in that they are all exacerbated by smoking and 
smoking cessation is of upmost importance in their management.  Most of these conditions 
are also included in the QOF and patients with these conditions are routinely invited to 
chronic disease management clinics in primary care, where smoking cessation interventions 
should be initiated.(16, 17)  The eight mental health conditions and 23 discordant physical 
conditions can be found in Appendix 2, with their prevalences in this population. 
 
Deprivation status 
Socioeconomic deprivation was quantified using the Carstairs score, grouped into quintiles.  
This area-based measure of deprivation, derived from census and other routine data, has been 
widely used in health research.(18)  
Statistical analysis 
Descriptive analysis of the study population examined how smoking status, receipt of 
smoking cessation advice, and receipt of NRT varied by patient characteristics.  For the three 
outcome variables of interest, multilevel binary logistic regression models were constructed 
in order to account for the clustering of patients within practices. Results are presented as 
univariate (crude) and multivariate (adjusted) odds ratios (ORs) and 95% confidence intervals 
(95% CI), with adjustment made for age group, sex, deprivation, and the three patterns of co-
morbidity.  Analysis was carried out using STATA-MP version 14.0 (Texas, USA).   
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RESULTS 
81,456 adults aged 25 and over with a recorded diagnosis of CHD were included in the first 
regression model, representing a prevalence of CHD in the population studied of 4.64% (95% 
CI 4.61 to 4.67).  The distribution of study variables and outcomes and the characteristics of 
the study population are presented in Tables 1 and 2 respectively.  
 
Smoking status 
Smoking status was recorded in 99.6% of people with CHD, with 16,745 (20.5%) recorded as 
current smokers and 35,967 (44.1%) as ex-smokers.  Table 3 shows the unadjusted and 
adjusted ORs of being a current smoker.  There were marked differences in the odds of being 
a smoker by age group, deprivation quintile, and different patterns of co-morbidity.  Fewer 
women were smokers than men, but in the fully adjusted model, differences between men and 
women were not statistically significant (OR 0.99, 95% CI 0.95 to 1.03). 
 
The odds of being a current smoker decreased with age, with lower odds for each age group 
compared to the reference group of under-55 year-olds (42.8% of whom were current 
smokers). The percentage of current smokers rose with increasing deprivation, from 11.5% in 
the most affluent quintile to 30.4% in the most deprived.  In the adjusted model, the odds of 
being a current smoker increased with each quintile of increased deprivation, such that those 
in the most deprived quintile had nearly three times the odds of being a current smoker 
compared to those in the most affluent quintile (OR 2.76, 95% CI 2.49 to 3.05). 
  
In terms of the effect of different patterns of co-morbidity, for people with one concordant 
physical co-morbidity, the odds of being a current smoker were reduced compared to those 
without (OR 0.88, 95% CI 0.84 to 0.93).  For those with 2 or more concordant co-
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morbidities, the odds ratio of being a smoker was not statistically significantly different.  The 
odds of being a current smoker also decreased with additional discordant physical co-
morbidities, from OR 0.86 (95% CI 0.83 to 0.90) for those with one discordant physical 
condition to OR 0.72 (95% CI 0.69 to 0.75) for those with two or more. Those with two or 
more co-morbid mental health conditions had more than twice the odds of being current 
smokers as those without (OR 2.11, 95% CI 1.99 to 2.24).  
 
Smoking cessation advice 
15,395 (91.9%) current smokers were recorded as being given smoking cessation advice in 
the previous 15 months.  Table 4 presents the multilevel binary logistic regression model for 
receipt of smoking cessation advice by current smokers.  In the adjusted model, women had 
slightly higher odds of receiving smoking cessation advice compared to men (OR 1.15, 95% 
CI 1.01 to 1.30), although absolute differences were small.   
 
In terms of deprivation status, adults with CHD from the most deprived quintile had lower 
odds of receiving smoking cessation advice compared to those in the most affluent quintile in 
the unadjusted model, but this was no longer statistically significant after adjustment (OR 
0.80, 95% CI 0.62 to 1.02).  It is worth noting that more than 90% of smokers in every 
quintile received advice, which was the QOF threshold for this target. 
 
Those with concordant physical conditions were more likely to receive smoking advice than 
those without, with OR 2.10 (95% CI 1.77 to 2.51) for those with two or more concordant 
physical conditions compared to those with none, but with small absolute differences (94.1% 
compared to 89.1%). There was a similar, though less marked, relationship between 
additional discordant physical conditions and receipt of smoking cessation advice.  Those 
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with mental health conditions had significantly lower odds of receiving smoking cessation 
advice (e.g. OR 0.74, 95% CI 0.62 to 0.88 for those with one mental health co-morbidity) but 
again, absolute differences were small.  
 
Smoking cessation medication 
There were 2427 (14.5%) current smokers who received a prescription for NRT in the 15 
months prior to data collection.  Table 5 presents the multilevel binary logistic regression 
model for receipt of NRT by current smokers.   
 
A greater proportion of women who were current smokers (17.1%) received NRT compared 
to men (12.8%; OR 1.48, 95% CI 1.35 to 1.62). The proportion of smokers receiving NRT 
decreased with age, such that 21.2% of those smokers aged under 55 received NRT, 
compared to just 7.1% of those aged 75 years and older (OR 0.22, 95% CI 0.19 to 0.27). In 
terms of deprivation, the percentage of smokers receiving NRT increased from 11.8% in the 
most affluent quintile to 15.7% in the most deprived quintile (OR 1.41, 95% CI 1.11 to 1.80).   
 
In terms of different patterns of co-morbidity, the percentage of smokers receiving NRT was 
13.2% for those with no concordant physical conditions and 15.4% for those with 2 or more 
concordant physical conditions (OR 1.39, 95% CI 1.24 to 1.56), with similar percentages for 
discordant physical conditions.  Smokers with one or more mental health condition were 
more likely to receive NRT (16.7% for one condition and 16.2% for two or more) than those 
without any mental health co-morbidity (13.1%).  In the adjusted model, however, the OR 
was only significant for those smokers with one mental health condition (OR 1.18, 95% CI 
1.07 to 1.31).   
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DISCUSSION 
Summary 
This large nationally representative cross-sectional study has highlighted marked differences 
in smoking status among adults with coronary heart disease, by age, sex, deprivation and 
different patterns of co-morbidity. Younger adults (<55 years), those living in the most 
deprived areas and those with mental health co-morbidities were more likely to be current 
smokers.    
 
The quality of smoking cessation care provided in primary care was generally high, with 
smoking status recorded in 99.6% of people with CHD, and recent smoking cessation advice 
recorded for 91.9% of current smokers, with only small absolute differences between groups. 
There was a modest but consistent trend for higher NRT prescription amongst those more 
deprived and those with more co-morbidities.  
Strengths and limitations 
The strengths of this study include the large size of the dataset (over 80,000 people with 
CHD), the fact it was nationally representative, and the relatively large number of co-morbid 
conditions included.  Limitations include it being a cross-sectional study so it is not possible 
to ascertain causality or temporality of any of the observed associations.  As with any 
secondary data analysis, the quality and validity of the findings are only as good as the 
quality of the original data.  In this case, confidence in the accuracy and consistency of the 
data is increased as the main outcome variables of interest were either collected routinely for 
QOF or were prescribing data, which are known to be well recorded.(19) With regard to NRT 
prescriptions, the observed trend for higher NRT prescriptions among those more deprived 
and those with more co-morbidities should be interpreted with caution, as the findings do not 
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account for over-the-counter (OTC) NRT, which was widely available at relatively low cost 
in the UK at the time of the study, but may be more affordable and accessible to the more 
affluent.(20, 21) 
 
Finally, we are unable to say what sort of smoking cessation advice was given or how often 
this was reinforced. The content and quality of GP ‘brief advice’ varies considerably, but this 
is not captured in our data; an important caveat when interpreting these results.(22, 23)  
Previous studies have demonstrated reluctance by GPs to discuss smoking in depth, with only 
a fraction of opportunities to give smoking advice taken up.(24, 25) The reasons for this 
reluctance are complex, but include lack of time, lack of confidence, and concerns about the 
impact on the doctor-patient relationship.(26, 27)  
 
Comparison with existing literature  
This study is one of only two that we are aware of that have assessed the associations 
between different patterns of co-morbidity and smoking rates and smoking cessation 
interventions in primary care for patients with coronary heart disease, and is the first to have 
examined ‘concordant’ co-morbidities in this regard.  Consistent with this paper, Hippisley-
Cox et al examined people with CHD and ‘serious mental health’ co-morbidity 
(predominately schizophrenia or bipolar disorder) and found that most CHD care indicators – 
including recording of smoking status and smoking cessation advice – were achieved equally 
for patients with and without a serious mental health problem.(28)  
 
Individuals with CHD and one or more mental health co-morbidity were more likely to be 
current smokers than those without, a finding that is consistent with previous research.(29-31)  
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The quality of care for physical health problems in people with mental health conditions has 
come under scrutiny.(5, 32) In a US study, smoking cessation counselling was included as 
one of five quality indicators used to compare the quality of care among patients with or 
without mental illness and the impact of this on risk of mortality 1 year post-MI was 
examined.(33)  Deficits in quality of care explained a substantial proportion of the excess 
mortality experienced by people with mental disorders after MI, but differences in smoking 
cessation counselling did not contribute to this.   
Implications for research and practice  
In this study approximately 85% of current smokers did not receive any NRT.  This may 
simply reflect the best practice recommendations to only prescribe NRT to those who are 
committed to stopping smoking.(34)  It is clear, however, that we need better ways of 
converting people with CHD who are current smokers into non-smokers, particularly for 
those from more deprived areas and those with mental health co-morbidity. 
  
Current NHS stop smoking services are reaching disadvantaged smokers,(35) but a number 
of other barriers exist, including more challenging life circumstances, lack of social support, 
and higher nicotine dependency.(36-38)  There are no easy solutions to these challenges,(39) 
but more proactive identification of smokers who want to quit, with referral to smoking 
cessation services, has been shown to increase quit attempts in previous primary care-based 
studies.(40, 41)  
 
With regard to mental health co-morbidity, the RCGP has produced succinct primary care 
guidance on smoking and mental health, which outlines the physical, mental and financial 
benefits of stopping smoking, and provides practitioners with advice on medication dose 
adjustment and monitoring of mental health during smoking cessation attempts.(42)  Clear 
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communication and co-ordination between smoking cessation services and prescribers in 
primary and secondary care is recommended.   
 
This study adds to a growing body of research that explores the effect of different 
combinations of co-morbidity on quality of care outcomes.(3, 43, 44)  The grouping of 
concordant ‘vascular’ physical conditions that we used in this study may be useful to clinical 
practice in the future, as they share a common pathophysiology or management.  The study 
also adds to the large body of evidence on disparities between those with physical and mental 
health problems.(5, 45, 46)  Improving integration and co-ordination of care for people with 
multimorbidity is one of the key healthcare challenges of the 21st century.(47, 48)  
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